In this prospective observational study, we analyzed circulating levels of IL-23, IL-17A, IL-17E, IL-17F, IL-1β, and IL-1RA in 127 patients with compensated cirrhosis, acute decompensation (AD), or ACLF in the absence of active infection. This evidence concerns the gene IL17A and Alzheimer disease.